LiveZilla Live Chat Software

Constellation, le dépôt institutionnel de l'Université du Québec à Chicoutimi

Screening and comorbidity of clinical levels of fear of cancer recurrence

Simard Sébastien et Savard Josée. (2015). Screening and comorbidity of clinical levels of fear of cancer recurrence. Journal of Cancer Survivorship, 9, (3), p. 481-491.

[img] PDF - Version publiée
Administrateurs seulement

258kB

URL officielle: http://dx.doi.org/10.1007/s11764-015-0424-4

Résumé

PURPOSE: The prevalence of clinical levels of fear of cancer recurrence (FCR) in cancer survivors is unknown, which may be partly explained by the lack of an assessment method that would make it possible to distinguish between normal and clinical levels of FCR. Moreover, despite the apparent overlap between FCR and manifestations of some psychiatric disorders, no study has yet evaluated the comorbidity of clinical levels of FCR. The goals of this study were to assess the capacity of the Fear of Cancer Recurrence Inventory severity subscale, to consider a shorter form of the FCRI (FCRI-SF), to screen for clinical levels of FCR, and to assess its psychiatric comorbidity.

METHODS: Sixty French-Canadian cancer survivors (73% of those eligible) who had been treated within the past 4 years for localized breast, prostate, lung, or colorectal cancer were randomly selected. Participants were administered a clinical interview assessing FCR, the Structured Clinical Interview for DSM-IV, and self-report scales.

RESULTS: A cutoff score of 13 or higher on the FCRI-SF was associated with optimal sensitivity (88%) and specificity (75%) rates for the screening of clinical levels of FCR. Cancer survivors with clinical levels of FCR were significantly more likely to meet the criteria for a current psychiatric disorder (60%) than patients with nonclinical levels (29%). Anxiety disorders tended to be the most common comorbid disorders.

CONCLUSIONS/IMPLICATIONS FOR CANCER SURVIVORS: The FCRI-SF allows rapid and effective screening of clinical levels of FCR, a condition associated with significant psychiatric comorbidity.

Type de document:Article publié dans une revue avec comité d'évaluation
Volume:9
Numéro:3
Pages:p. 481-491
Version évaluée par les pairs:Oui
Date:2015
Sujets:Sciences sociales et humaines > Sciences sociales > Psychologie
Sciences de la santé
Département, module, service et unité de recherche:Départements et modules > Département des sciences de la santé > Module de psychologie
Mots-clés:Cancer, Fear of cancer recurrence, Fear of progression, Screening, Clinical levels, Comorbidity, Psychiatric disorders, peur de récidive de cancer, progression de la maladie, comorbidité, problèmes psychiatriques, détection de la maladie
Déposé le:19 déc. 2017 23:07
Dernière modification:19 déc. 2017 23:07
Afficher les statistiques de telechargements

Éditer le document (administrateurs uniquement)

Creative Commons LicenseSauf indication contraire, les documents archivés dans Constellation sont rendus disponibles selon les termes de la licence Creative Commons "Paternité, pas d'utilisation commerciale, pas de modification" 2.5 Canada.

Bibliothèque Paul-Émile-Boulet, UQAC
555, boulevard de l'Université
Chicoutimi (Québec)  CANADA G7H 2B1
418 545-5011, poste 5630